BioRestorative Therapies BRTX
NASDAQ BRTX
$0.22 -0.01 (-2.31%)
As of: Aug 21, 2026 · 1:52 PM EDT

BioRestorative Therapies (BRTX) EBITDA Margin (QoQ) (2012 - 2025)

BioRestorative Therapies (BRTX) EBITDA Margin (QoQ) (2012 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.50 Bn 131.65 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.10 Bn 78.10 Bn 3.93 Bn
3 Argenx Se 65.59 Bn 60.41 Bn 1.37 Bn
4 Moderna 56.75 Bn 51.62 Bn 52.00 Mn
5 BeOne Medicines 42.11 Bn 37.01 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.64 Bn 28.33 Bn 992.69 Mn
7 BioNTech SE 27.80 Bn 9.41 Bn 668.28 Mn
8 Insmed 27.51 Bn 26.35 Bn 358.27 Mn
9 Royalty Pharma 27.29 Bn 26.45 Bn -
10 BioRestorative Therapies 1.94 Mn -1.01 Mn 17,964.00

Historic Data

Download Data
DateValue
Dec 31, 2025 1.19 Mn
Sep 30, 2025 -3.03 Mn
Jun 30, 2025 1.81 Mn
Mar 31, 2025 -1.30 Mn
Dec 31, 2024 -523,378.00
Sep 30, 2024 179,181.00
Jun 30, 2024 896,989.00
Mar 31, 2024 494,675.00
Dec 31, 2023 -657,528.00
Sep 30, 2023 -528,033.00
Jun 30, 2023 1.36 Mn
Mar 31, 2023 10.81 Mn
Dec 31, 2022 -11.06 Mn
Sep 30, 2022 -938,549.00
Jun 30, 2022 2.51 Mn
Mar 31, 2022 4.86 Mn
Dec 31, 2021 -3.41 Mn
Sep 30, 2021 -2.24 Mn
Jun 30, 2021 5.99 Mn
Mar 31, 2021 -7.86 Mn